// App-Quantinova.ai

2.4 1825 : Early clinical development plan for a novel virus like particle displaying Ara h 2 for the subcutaneous treatment of peanut allergy

Researchers

Presenter

  • Oluwayi K

Principal Investigators

  • Blmchen K

  • Beyer K

  • Shamji MH

  • Jones C

  • Skinner MA

  • Heath

  • Kramer MF

  • Kndig TM

  • Bachmann MF

  • De Kam PJ

Medical Centers

  • Allergy Therapeutics Ltd, Worthing, United Kingdom

  • Departement for Children and Adolescent,Division for Allergy, Pneumology and Cystic Fibrosis, University Hospital Frankfurt, Frankfurt am Main, Germany

  • Department of Pediatric Pneumology and Immunology, University Hospital Charité, Berlin, Germany

  • Department of Medicine / National Heart & Lung Institute, Imperial College London, London, United Kingdom

  • Bencard Allergie Gmbh, Munich, Germany

  • Department of Neurology, University Hospital Zurich, Zurich, Switzerland

  • Rheumatology, Inselspital-University Hospital, Bern, Switzerland,

Locations

  • United Kingdom

  • Germany

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved